Discover 1,166 paid clinical trials in Pittsburgh, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,166
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
for
Overactive Bladder (OAB), Urinary Urgency,
Location: Pittsburgh PA, Washington D.C. DC, Winston-Salem NC,
Sponsor: Medstar Health Research Institute
Sex: Female
Age: 22+
Code: NCT06797245
Recruiting
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Pittsburgh PA, Canton OH, Mayfield Heights OH,
Sponsor: Ottawa Heart Institute Research Corporation
Sex: All
Age: 18+
Code: NCT03593759
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: Pittsburgh PA, Jefferson Hills PA, Monroeville PA,
Sponsor: NRG Oncology
Sex: Female
Age: 35 - 50
Code: NCT04251052
Recruiting
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
for
Early Breast Cancer
Location: Pittsburgh PA, Silver Spring MD, Baltimore MD, Toronto,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT05827081
Phase 3, Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
for
Metastatic Renal Cell Carcinoma,
Location: Pittsburgh PA, Jefferson Hills PA, Monroeville PA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT05327686
Phase 2, Recruiting
A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC